Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-08-05
2000-10-03
Ramsuer, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483741, A61K 31415, A61P 2524, C07D23114
Patent
active
061273996
ABSTRACT:
Disclosed are compounds that are highly selective partial agonists or antagonists at human CRF.sub.1 receptors that are useful in the diagnosis and treatment of treating stress related disorders such as post traumatic stress disorder (PTSD) as well as depression, headache and anxiety. The compounds have the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein Ar, R.sub.1, R.sub.2, A, and Z are various organic and inorganic substituents.
REFERENCES:
patent: 5760225 (1998-06-01), Yuan
patent: 5973152 (1999-10-01), Yuan
Neurogen Corporation
Ramsuer Robert
Sarussi Steven
LandOfFree
Certain pyrazole derivatives as cortiocotropin-releasing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain pyrazole derivatives as cortiocotropin-releasing factor , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain pyrazole derivatives as cortiocotropin-releasing factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-196216